LymphomaStomach lymphoma is an unusual type of cancer that has its origin in the stomach's lymphatic tissue. Among the subtypes, mucosa-associated lymphoid tissue (MALT) lymphoma is the most ...

Moreover, a study focusing on gastric mucosa-associated lymphoid tissue (MALT) lymphoma highlighted the potential of [68Ga]Pentixafor PET as a non-invasive alternative to traditional biopsy ...

The final draft of the manuscript was reviewed and approved by all participants. Gastric mucosa-associated lymphoid tissue (MALT) lymphoma is a rare disease. As a consequence of this, there are no ...

ET-901 is under clinical development by EdiGene and currently in Phase II for Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue or MALT-Lymphoma). According to GlobalData, ...

ET-901 is under clinical development by EdiGene and currently in Phase II for B-Cell Non-Hodgkin Lymphoma. According to GlobalData, Phase II drugs for B-Cell Non-Hodgkin Lymphoma have a 36% phase ...

an isolated mild sclerodactyly and a Mucosa Associated Lymphoid Tissue (MALT) lymphoma. The scleroderma dot-blot assay was negative. He was the third patient with positive criteria of MCTD by Kasukawa ...

Not all patients had a visit at 6 months after baseline, since this visit was only performed on clinical indication (ie, having a moderate or high disease activity according to ESSDAI, severe ...

The deregulation of the “B-cell lymphoma-2” (BCL2) family in mature B cell malignancies ... mucosa-associated lymphoid tissue (MALT), SMZL, MM, through normalization of Affymetrix Human Genome U133 ...

Janssen Pharmaceutica NV has divulged mucosa associated lymphoid tissue lymphoma translocation protein 1 (MALT1) inhibitors reported to be useful for the treatment of cancer.

ASH 2024 featured practice-changing studies in lymphoid malignancies, including tafasitamab’s impact in FL, ibrutinib’s OS benefit in MCL, and promising epcoritamab data in CLL.